查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1933277

數位病理市場規模、佔有率、成長及全球產業分析：依類型、應用和地區劃分的洞察，預測（2026-2034 年）

Digital Pathology Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 149 Pages | 商品交期: 請詢問到貨日

價格

數位病理市場成長驅動因素

受慢性病發病率上升、住院人數增加以及傳統病理工作流程中數位化工具的廣泛應用等因素的推動，全球數位病理市場正經歷快速增長。數位病理利用全切片掃描儀和數位顯微鏡創建數位切片，然後使用高通量演算法進行分析，遠端共享並儲存以供將來參考。 這些創新正在改變現代診斷，在減輕病理學家工作量的同時，實現更快、更準確的分析。

根據 Fortune Business Insights 的數據顯示，2025 年該市場價值 13 億美元，預計 2026 年將成長至 14.7 億美元，到 2034 年將達到 57.5 億美元。這意味著 2026 年至 2034 年的複合年增長率 (CAGR) 為 18.56%。北美在 2025 年佔市場主導地位，市佔率達 36.74%，這得益於其強大的數位基礎設施、早期採用人工智慧驅動的病理診斷解決方案以及對先進診斷技術的高度認知。在美國，受 FDA 支持數位化以及遠端審查和分析數位切片政策的推動，預計到 2032 年，數位病理市場規模將達到 13 億美元。

市場驅動因素

慢性病發病率上升：慢性病發病率和住院率的上升推動了對快速、準確的病理檢測的需求。研究表明，數位化提高了效率，病理學家報告稱，與傳統工作流程相比，生產力提高了 15%。此外，數位平台在預測分析和帕金森氏症等疾病的早期診斷方面的應用日益廣泛，進一步推動了市場成長。

新冠疫情的影響：疫情導致面對面諮詢減少，以及緊急監管審批的出台，加速了病理學領域數位轉型。 2020 年 4 月，美國食品藥物管理局 (FDA) 實施了一項政策，允許遠端審查數位切片。 受遠端病理學（遠端病理診斷）和遠端診斷技術廣泛應用的推動，2020 年市場成長了 31.2%，高於 2019 年的 11.6%。儘管疫情消退後患者數量恢復到疫情前水平，但數位化解決方案的採用率仍然很高，支撐了市場成長動能。

人工智慧 (AI) 的整合：基於人工智慧的數位化工具正在透過實現高級影像分析、工作流程管理和基於深度學習的診斷來變革病理學。例如，羅氏於 2021 年 12 月發布了一種用於乳癌標記評估的人工智慧演算法，而 Sigtuple 的人工智慧輔助血液抹片檢測應用於 2023 年 9 月獲得了 FDA 的批准。這些進步提高了診斷準確性和營運效率。

市場限制因子

高昂的初始成本：實施一套數位病理系統，包括高通量掃描儀、軟體和儲存解決方案，需要大量的投資。 數位切片掃描器的價格從 10 萬美元到 40 萬美元不等，還不包括培訓、技術支援和授權費用。小型實驗室往往難以實施這些工具，從而限制了市場滲透率。此外，病理學家短缺——每 10 萬人口淨減少 5700 名病理學家——進一步阻礙了某些地區的普及。

市場區隔

依產品類型劃分：

  • 硬體：到 2026 年，硬體將佔 58.10% 的市場佔有率，主要受對掃描儀和組織微陣列儀器的需求驅動，這些儀器可以加速病理診斷。
  • 軟體：到 2024 年，軟體將佔 35.2% 的市場佔有率，主要受對基於人工智慧的影像分析、病理管理和數位顯微鏡檢視器的需求所驅動。
  • 儲存系統：成長的驅動力是對安全資料儲存和共享的需求。

依應用領域劃分：

  • 疾病診斷：預計到 2026 年，該細分市場將佔 54.96% 的市場佔有率，主要受診斷檢測需求增長和早期檢測舉措的推動。
  • 藥物研發：高通量篩選與在研藥物需求推動快速成長。

依最終使用者劃分：

  • 醫院和診所：預計到 2026 年，該細分市場將佔主導地位，市場佔有率達到 62.18%，主要受患者數量增長和人工智慧輔助數位病理系統應用的推動。
  • 臨床實驗室：由於玻片數位化和人工智慧驅動的協作解決方案，該細分市場將實現成長。

區域洞察

北美：預計到 2025 年，市場規模將達到 4.8 億美元，到 2026 年將達到 5 億美元。主要驅動因素包括慢性病高發生率、人口老化以及工作流程日益數位化。

歐洲：第二大市場，受惠於技術進步、監管審批和人工智慧解決方案。預計到 2026 年，英國市場規模將達到 5,000 萬美元，德國市場規模將達到 1.1 億美元。

亞太地區：成長最快的地區，受益於醫療基礎設施的不斷完善、公共和私人投資的增加以及患者人數的增長。 預計到 2026 年，日本將達到 9,000 萬美元，中國將達到 7,000 萬美元，印度將達到 5,000 萬美元。

拉丁美洲、中東和非洲：醫療旅遊、醫療保健投資以及數位病理工具的採用預計將推動穩定成長。

主要公司與產業趨勢

主要公司包括 F. Hoffmann-La Roche、Thermo Fisher Scientific、Hamamatsu Photonics、3DHISTECH、Philips、Apollo Enterprise Imaging、Sectra 和 Huron Technologies。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 主要產業發展：併購與合作
  • 數位病理技術進步
  • 2024年全球數位健康市場概覽
  • 新冠疫情對市場的影響

第五章：全球數位病理學市場分析、洞察與預測 2021-2034

  • 市場分析、洞察與預測：依產品分類
    • 硬體
      • 掃描儀
      • 組織微陣列設備
      • 其他
    • 軟體
      • 病理管理
      • 數位顯微鏡觀察器
      • 影像分析設備
      • 其他
    • 儲存系統
  • 市場分析、洞察與預測：依應用分類
    • 疾病診斷
    • 藥物研發
    • 其他
  • 市場分析、洞察與預測：依最終用戶分類
    • 醫院和診所
    • 臨床實驗室
    • 其他
  • 市場分析、洞察與預測：依區域
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章：北美數位病理市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲數位病理市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞半島
    • 歐洲其他地區

第八章：亞太數字病理市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章：拉丁美洲數位病理學市場分析、洞察與預測，2021–2034

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第十章：中東與非洲數位病理學市場分析、洞察與預測，2021–2034

  • 依國家劃分
    • 海灣合作委員會國家
    • 南亞國家非洲
    • 中東和非洲其他地區

第十一章 競爭分析

  • 全球市佔率分析（2024 年）
  • 公司簡介
    • Leica Biosystems Nussloch GmbH
    • Thermo Fisher Scientific Inc.
    • F. Hoffmann-La Roche Ltd
    • Hamamatsu Photonics K.K.
    • Akoya Biosciences, Inc.
    • 3DHISTECH Ltd.
    • Koninklijke Philips N.V.
    • Apollo Enterprise Imaging Corp
    • Sectra AB
    • Huron Technologies International Inc.
Product Code: FBI100229

Growth Factors of digital pathology Market

The global digital pathology market is witnessing rapid growth, driven by the rising prevalence of chronic diseases, increased hospital admissions, and the growing adoption of digital tools in traditional pathology workflows. Digital pathology involves creating digital slides through whole-slide scanning devices or digital microscopes, which can then be analyzed using high-throughput algorithms, shared remotely, or stored for future reference. These innovations have transformed modern diagnostics, enabling faster and more accurate analysis while reducing workload for pathologists.

According to Fortune Business Insights, the market was valued at USD 1.3 billion in 2025, projected to grow to USD 1.47 billion in 2026, and estimated to reach USD 5.75 billion by 2034, reflecting a CAGR of 18.56% from 2026 to 2034. North America dominated the market in 2025 with a 36.74% share, led by robust digital infrastructure, early adoption of AI-powered pathology solutions, and high awareness of advanced diagnostics. In the U.S., the digital pathology market is projected to reach USD 1.30 billion by 2032, supported by increasing digitization and favorable FDA policies for remote review and analysis of digital slides.

Market Drivers

Rising Burden of Chronic Diseases: The increasing incidence of chronic conditions and hospitalizations is boosting demand for timely and accurate pathology tests. Studies indicate that digitization enhances efficiency, with pathologists reporting a 15% productivity increase compared to traditional workflows. Additionally, digital platforms are increasingly used for predictive analysis and early diagnosis of diseases, such as Parkinson's disease, further stimulating market growth.

COVID-19 Impact: The pandemic accelerated digital adoption in pathology due to reduced in-person consultations and emergency regulatory approvals. The U.S. FDA implemented policies in April 2020 allowing remote reviewing of digital slides. The market saw a 31.2% growth in 2020, compared to 11.6% in 2019, driven by telepathology and remote diagnostics. Post-pandemic, patient volumes returned to pre-pandemic levels, but adoption of digital solutions remained high, sustaining growth momentum.

Integration of Artificial Intelligence: AI-based digital tools are transforming pathology by enabling advanced image analysis, workflow management, and deep learning-based diagnostics. For example, Roche launched AI algorithms in December 2021 for breast cancer marker evaluation, and Sigtuple received FDA approval in September 2023 for its AI-assisted blood smear application. Such advancements improve diagnostic accuracy and operational efficiency.

Market Restraints

High Upfront Costs: The installation of digital pathology systems, including high-throughput scanners, software, and storage solutions, involves substantial investment. Digital slide scanners range from USD 100,000 to USD 400,000, excluding costs for training, technical support, and licensing. Smaller laboratories often struggle to afford these tools, which limits market penetration. Additionally, the shortage of pathologists, with a net deficit of 5,700 per 100,000 population, further hinders adoption in certain regions.

Market Segmentation

By Product Type:

  • Hardware: Dominates with 58.10% share in 2026, driven by demand for scanners and tissue microarrayers for timely pathology outcomes.
  • Software: Holds 35.2% share in 2024, fueled by AI-based image analysis, pathology management, and digital microscopy viewers.
  • Storage Systems: Supporting growth due to the need for secure data storage and sharing.

By Application:

  • Disease Diagnosis: Leading segment with 54.96% market share in 2026, driven by rising diagnostic testing requirements and early detection initiatives.
  • Drug Discovery: Growing rapidly due to high-throughput screening and demand for pipeline drugs.

By End User:

  • Hospitals & Clinics: Dominant with 62.18% share in 2026, supported by rising patient admissions and adoption of AI-assisted digital pathology systems.
  • Clinical Laboratories: Expanding segment due to digitization of slides and collaborative AI-driven solutions.

Regional Insights

North America: Market size USD 0.48 billion in 2025, projected at USD 0.5 billion by 2026, driven by high chronic disease prevalence, geriatric population, and workflow digitization initiatives.

Europe: Second-largest market, supported by technological advancements, regulatory approvals, and AI-based solutions. The UK market is projected at USD 0.05 billion by 2026, and Germany at USD 0.11 billion by 2026.

Asia Pacific: Fastest-growing region due to expanding healthcare infrastructure, public and private investments, and increasing patient volumes. Japan is projected at USD 0.09 billion, China at USD 0.07 billion, and India at USD 0.05 billion by 2026.

Latin America & Middle East & Africa: Steady growth is driven by medical tourism, healthcare investments, and adoption of digital pathology tools.

Key Players & Industry Developments

Prominent companies include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Hamamatsu Photonics K.K., 3DHISTECH Ltd., Koninklijke Philips N.V., Apollo Enterprise Imaging Corp., Sectra AB, and Huron Technologies.

Recent Developments:

  • February 2024: Roche partnered with PathAI to develop AI algorithms for tissue diagnostics.
  • October 2023: Roche collaborated with Ibex and AWS for AI-enabled breast and prostate cancer diagnostics.
  • August 2023: PathAI launched AISight Digital Pathology Image Management System.
  • April 2022: 3DHISTECH deployed digital pathology tools across 8 hospitals in Spain.

Conclusion

The global digital pathology market is projected to grow from USD 1.3 billion in 2025 to USD 1.47 billion in 2026, reaching USD 5.75 billion by 2034 at a CAGR of 18.56%. Market growth is driven by increasing chronic disease burden, digitization of pathology workflows, integration of AI, and rising adoption of high-throughput diagnostic tools. Despite challenges like high upfront costs and shortage of pathologists, ongoing technological advancements, regulatory support, and strategic partnerships by key players are expected to sustain the market's robust growth globally.

Segmentation By Product

  • Hardware
    • Scanners
    • Tissue Microarrayer
    • Others
  • Software
    • Pathology Management
    • Digital Microscopy Viewers
    • Image Analyzers
    • Others
  • Storage Systems

By Application

  • Disease Diagnosis
  • Drug Discovery
  • Others

By End-user

  • Hospitals & Clinics
  • Clinical Laboratories
  • Others

By Geography

  • North America (By Product, Application, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Product, Application, End-user, and Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product, Application, End-user, and Country/Sub-Region)
    • China
    • India
    • Japan
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product, Application, End-user, and Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product, Application, End-user, and Country/Sub-Region)
    • GCC
    • South Africa
  • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Key Industry Developments- Mergers, Acquisitions and Partnerships
  • 4.2. Technological Advancements in Digital Pathology
  • 4.3. Snapshot: Global Digital Health Market, 2024
  • 4.4. Impact of COVID-19 on the Market

5. Global Digital Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Hardware
      • 5.1.1.1. Scanners
      • 5.1.1.2. Tissue Microarrayer
      • 5.1.1.3. Others
    • 5.1.2. Software
      • 5.1.2.1. Pathology Management
      • 5.1.2.2. Digital Microscopy Viewers
      • 5.1.2.3. Image Analyzers
      • 5.1.2.4. Others
    • 5.1.3. Storage Systems
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Disease Diagnosis
    • 5.2.2. Drug Discovery
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals & Clinics
    • 5.3.2. Clinical Laboratories
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Digital Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Hardware
      • 6.1.1.1. Scanners
      • 6.1.1.2. Tissue Microarrayer
      • 6.1.1.3. Others
    • 6.1.2. Software
      • 6.1.2.1. Pathology Management
      • 6.1.2.2. Digital Microscopy Viewers
      • 6.1.2.3. Image Analyzers
      • 6.1.2.4. Others
    • 6.1.3. Storage Systems
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Disease Diagnosis
    • 6.2.2. Drug Discovery
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals & Clinics
    • 6.3.2. Clinical Laboratories
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Digital Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Hardware
      • 7.1.1.1. Scanners
      • 7.1.1.2. Tissue Microarrayer
      • 7.1.1.3. Others
    • 7.1.2. Software
      • 7.1.2.1. Pathology Management
      • 7.1.2.2. Digital Microscopy Viewers
      • 7.1.2.3. Image Analyzers
      • 7.1.2.4. Others
    • 7.1.3. Storage Systems
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Disease Diagnosis
    • 7.2.2. Drug Discovery
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals & Clinics
    • 7.3.2. Clinical Laboratories
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Digital Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Hardware
      • 8.1.1.1. Scanners
      • 8.1.1.2. Tissue Microarrayer
      • 8.1.1.3. Others
    • 8.1.2. Software
      • 8.1.2.1. Pathology Management
      • 8.1.2.2. Digital Microscopy Viewers
      • 8.1.2.3. Image Analyzers
      • 8.1.2.4. Others
    • 8.1.3. Storage Systems
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Disease Diagnosis
    • 8.2.2. Drug Discovery
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals & Clinics
    • 8.3.2. Clinical Laboratories
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Digital Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Hardware
      • 9.1.1.1. Scanners
      • 9.1.1.2. Tissue Microarrayer
      • 9.1.1.3. Others
    • 9.1.2. Software
      • 9.1.2.1. Pathology Management
      • 9.1.2.2. Digital Microscopy Viewers
      • 9.1.2.3. Image Analyzers
      • 9.1.2.4. Others
    • 9.1.3. Storage Systems
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Disease Diagnosis
    • 9.2.2. Drug Discovery
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals & Clinics
    • 9.3.2. Clinical Laboratories
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Digital Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product
    • 10.1.1. Hardware
      • 10.1.1.1. Scanners
      • 10.1.1.2. Tissue Microarrayer
      • 10.1.1.3. Others
    • 10.1.2. Software
      • 10.1.2.1. Pathology Management
      • 10.1.2.2. Digital Microscopy Viewers
      • 10.1.2.3. Image Analyzers
      • 10.1.2.4. Others
    • 10.1.3. Storage Systems
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Disease Diagnosis
    • 10.2.2. Drug Discovery
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Hospitals & Clinics
    • 10.3.2. Clinical Laboratories
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.4.1. GCC Countries
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles
    • 11.2.1. Leica Biosystems Nussloch GmbH
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT analysis
      • 11.2.1.4. Recent developments
      • 11.2.1.5. strategies
      • 11.2.1.6. financials (based on availability)
    • 11.2.2. Thermo Fisher Scientific Inc.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT analysis
      • 11.2.2.4. Recent developments
      • 11.2.2.5. strategies
      • 11.2.2.6. financials (based on availability)
    • 11.2.3. F. Hoffmann-La Roche Ltd
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT analysis
      • 11.2.3.4. Recent developments
      • 11.2.3.5. strategies
      • 11.2.3.6. financials (based on availability)
    • 11.2.4. Hamamatsu Photonics K.K.
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT analysis
      • 11.2.4.4. Recent developments
      • 11.2.4.5. strategies
      • 11.2.4.6. financials (based on availability)
    • 11.2.5. Akoya Biosciences, Inc.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT analysis
      • 11.2.5.4. Recent developments
      • 11.2.5.5. strategies
      • 11.2.5.6. financials (based on availability)
    • 11.2.6. 3DHISTECH Ltd.
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT analysis
      • 11.2.6.4. Recent developments
      • 11.2.6.5. strategies
      • 11.2.6.6. financials (based on availability)
    • 11.2.7. Koninklijke Philips N.V.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT analysis
      • 11.2.7.4. Recent developments
      • 11.2.7.5. strategies
      • 11.2.7.6. financials (based on availability)
    • 11.2.8. Apollo Enterprise Imaging Corp
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT analysis
      • 11.2.8.4. Recent developments
      • 11.2.8.5. strategies
      • 11.2.8.6. financials (based on availability)
    • 11.2.9. Sectra AB
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT analysis
      • 11.2.9.4. Recent developments
      • 11.2.9.5. strategies
      • 11.2.9.6. financials (based on availability)
    • 11.2.10. Huron Technologies International Inc.
      • 11.2.10.1. Overview
      • 11.2.10.2. Products
      • 11.2.10.3. SWOT analysis
      • 11.2.10.4. Recent developments
      • 11.2.10.5. strategies
      • 11.2.10.6. financials (based on availability)

List of Tables

  • Table 1: Global Digital Pathology Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 2: Global Digital Pathology Market Revenue (USD billion) Forecast, by Hardware, 2021-2034
  • Table 3: Global Digital Pathology Market Revenue (USD billion) Forecast, by Software, 2021-2034
  • Table 4: Global Digital Pathology Market Revenue (USD billion) Forecast, by Applications, 2021-2034
  • Table 5: Global Digital Pathology Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 6: Global Digital Pathology Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 7: North America Digital Pathology Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 8: North America Digital Pathology Market Revenue (USD billion) Forecast, by Hardware, 2021-2034
  • Table 9: North America Digital Pathology Market Revenue (USD billion) Forecast, by Software, 2021-2034
  • Table 10: North America Digital Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 11: North America Digital Pathology Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 12: North America Digital Pathology Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 13: Europe Digital Pathology Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 14: Europe Digital Pathology Market Revenue (USD billion) Forecast, by Hardware, 2021-2034
  • Table 15: Europe Digital Pathology Market Revenue (USD billion) Forecast, by Software, 2021-2034
  • Table 16: Europe Digital Pathology Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 17: Europe Digital Pathology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 18: Asia Pacific Digital Pathology Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 19: Asia Pacific Digital Pathology Market Revenue (USD billion) Forecast, by Hardware, 2021-2034
  • Table 20: Asia Pacific Digital Pathology Market Revenue (USD billion) Forecast, by Software, 2021-2034
  • Table 21: Asia Pacific Digital Pathology Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 22: Asia Pacific Digital Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 23: Asia Pacific Digital Pathology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 24: Latin America Digital Pathology Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 25: Latin America Digital Pathology Market Revenue (USD billion) Forecast, by Hardware, 2021-2034
  • Table 26: Latin America Digital Pathology Market Revenue (USD billion) Forecast, by Software, 2021-2034
  • Table 27: Latin America Digital Pathology Market Revenue (USD billion) Forecast, by Applications, 2021-2034
  • Table 28: Latin America Digital Pathology Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 29: Latin America Digital Pathology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 30: Middle East & Africa Digital Pathology Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 31: Middle East & Africa Digital Pathology Market Revenue (USD billion) Forecast, by Hardware, 2021-2034
  • Table 32: Middle East & Africa Digital Pathology Market Revenue (USD billion) Forecast, by Software, 2021-2034
  • Table 33: Middle East & Africa Digital Pathology Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 34: Middle East & Africa Digital Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 35: Middle East & Africa Digital Pathology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Digital Pathology Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Digital Pathology Market Value Share (%), by Product, 2025 & 2034
  • Figure 3: Global Digital Pathology Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Digital Pathology Market Value Share (%), by End-user, 2025 & 2034
  • Figure 5: Global Digital Pathology Market Value (USD billion), by Region, 2025 & 2034
  • Figure 6: North America Digital Pathology Market Value (USD billion), by Product, 2025 & 2034
  • Figure 7: North America Digital Pathology Market Value Share (%), by Product, 2024
  • Figure 8: North America Digital Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 9: North America Digital Pathology Market Value Share (%), by Application, 2024
  • Figure 10: North America Digital Pathology Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 11: North America Digital Pathology Market Value Share (%), by End-user, 2024
  • Figure 12: North America Digital Pathology Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Digital Pathology Market Value Share (%), By Country, 2024
  • Figure 14: Europe Digital Pathology Market Value (USD billion), by Product, 2025 & 2034
  • Figure 15: Europe Digital Pathology Market Value Share (%), by Product, 2024
  • Figure 16: Europe Digital Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Europe Digital Pathology Market Value Share (%), by Application, 2024
  • Figure 18: Europe Digital Pathology Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 19: Europe Digital Pathology Market Value Share (%), by End-user, 2024
  • Figure 20: Europe Digital Pathology Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Digital Pathology Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 22: Asia Pacific Digital Pathology Market Value (USD billion), by Product, 2025 & 2034
  • Figure 23: Asia Pacific Digital Pathology Market Value Share (%), by Product, 2024
  • Figure 24: Asia Pacific Digital Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Digital Pathology Market Value Share (%), by Application, 2024
  • Figure 26: Asia Pacific Digital Pathology Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 27: Asia Pacific Digital Pathology Market Value Share (%), by End-user, 2024
  • Figure 28: Asia Pacific Digital Pathology Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Digital Pathology Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 30: Latin America Digital Pathology Market Value (USD billion), by Product, 2025 & 2034
  • Figure 31: Latin America Digital Pathology Market Value Share (%), by Product, 2024
  • Figure 32: Latin America Digital Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 33: Latin America Digital Pathology Market Value Share (%), by Application, 2024
  • Figure 34: Latin America Digital Pathology Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 35: Latin America Digital Pathology Market Value Share (%), by End-user, 2024
  • Figure 36: Latin America Digital Pathology Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Digital Pathology Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 38: Middle East & Africa Digital Pathology Market Value (USD billion), by Product, 2025 & 2034
  • Figure 39: Middle East & Africa Digital Pathology Market Value Share (%), by Product, 2024
  • Figure 40: Middle East & Africa Digital Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Digital Pathology Market Value Share (%), by Application, 2024
  • Figure 42: Middle East & Africa Digital Pathology Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 43: Middle East & Africa Digital Pathology Market Value Share (%), by End-user, 2024
  • Figure 44: Middle East & Africa Digital Pathology Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Digital Pathology Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 46: Global Digital Pathology Market Share (%), By Company, 2024